. Randomized Phase I Trial of the α-Synuclein Antibody Lu AF82422. Mov Disord. 2024 Jun;39(6):936-944. Epub 2024 Mar 17 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Therapeutics

  1. LU AF82422